Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/1/2000
 
First Published:
1/1/1999
1.
Phase II Randomized Study of Polyvalent Melanoma Vaccine Encapsulated into pH-Sensitive Liposomes in Patients with Stage IIB or III Malignant Melanoma (Summary Last Modified 03/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
NCI
NYU-9615
NCI-G98-1488
Last Modified:
6/1/2007
 
First Published:
11/1/1999
2.
Phase II Randomized Study of Polyvalent Melanoma Vaccine and Interleukin-2 Liposome With or Without One of Two Doses of Interferon alfa-2b in Patients With Stage III Malignant Melanoma (Summary Last Modified 08/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
NCI
NYU-9837
NCI-G99-1595, NCT00004104
Last Modified:
8/1/1997
3.
Phase I Pharmacokinetic Study of IL-2 Encapsulated in Liposomes in Patients with Refractory Cancer (Summary Last Modified 08/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
BRMP-9104
NCI-91-C-192, NCI-T91-0119N, T91-0119
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute